Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan’s Medical Insurance Agency Approves NHI Listing For Pfizer’s Macugen, Novartis’ Simulect, Merck Serono's Erbitux Among Others

This article was originally published in PharmAsia News

Executive Summary

Japan's Central Social Insurance Medical Council (Chuikyo) approved Aug. 27 11 drugs to be NHI listed. The drugs priced based on similar drugs include Astellas's Irribow (ramosetron) to treat male irritable bowel syndrome, Pfizer's Macugen (pegaptanib) to treat age-related macular degeneration, Taiho Pharmaceutical's Zosyn (piperacillin/tazobactam), Schering Plough's Nasonex (mometasone furoate), and Galderma's Differin Gel (adapalene). The drugs priced based on a cost accounting system include Pfizer's Mycobutin (rifabutin), Merck Serono's colon cancer drug Erbitux (cetuximab) and Genzyme Japan's Thymoglobulin to treat acute rejection of transplants. Additional drugs to be listed include Astellas' Prograf (tacrolimus) and Novartis' Simulect Pediatric (basiliximab). (Click here for more - Japanese language

You may also be interested in...

US Startup Ignites Consumer Health Portfolio Build With North American Rights To ThermaCare

Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.

US FDA Critic Leads House Appropriators, Consumer Health Ally Heads Energy And Commerce

Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.

CMS Final Medicare Outpatient Rule Gives Patients More Surgical Site Choices, At Lower Costs

The US Medicare agency is offering more lower-cost alternative sites for 2021 surgical procedures to be covered under its OPPS and ASC final rule.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts